Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

246
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
246
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

603
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
603
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

614
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
614
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

164
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
164
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

693
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
693

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Next Generation of Population-Based DFNB16 Carrier Screening and Diagnosis: STRC Copy-Number Variant Analysis from Genome Sequencing Data.

Clinical chemistryยท2023
Same author

A paternal protein facilitates sperm RNA delivery to regulate zygotic development.

Science China. Life sciencesยท2023
Same author

Yes-associated protein inhibition ameliorates liver fibrosis and acute and chronic liver failure by decreasing ferroptosis and necroptosis.

Heliyonยท2023
Same author

Editorial: Neurosyphilis: epidemiology, clinical manifestations, diagnosis, immunology and treatment.

Frontiers in medicineยท2023
Same author

Brain Emotion Perception Inspired EEG Emotion Recognition With Deep Reinforcement Learning.

IEEE transactions on neural networks and learning systemsยท2023
Same author

Efficacy and safety of flow diverter combined with coil embolization and evidence-based antithrombotic regimen in the treatment of ruptured aneurysms.

Neurosurgical focusยท2023

Related Experiment Video

Updated: Dec 28, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.7K

Feature rearrangement based deep learning system for predicting heart failure mortality.

Zhe Wang1, Yiwen Zhu2, Dongdong Li2

  • 1Key Laboratory of Advanced Control and Optimization for Chemical Processes, Ministry of Education, East China University of Science and Technology, Shanghai 200237, PR China; Department of Computer Science and Engineering, East China University of Science and Technology, Shanghai 200237, PR China.

Computer Methods and Programs in Biomedicine
|February 17, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces a fast and accurate deep learning framework for predicting heart failure mortality, effectively addressing data imbalance and improving feature representation for better patient outcomes.

Keywords:
Deep learningFeature rearrangement convolutionHeart failure

Related Experiment Videos

Last Updated: Dec 28, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.7K

Area of Science:

  • Medical Informatics
  • Machine Learning
  • Cardiology

Background:

  • Heart failure (HF) mortality prediction is critical for patient care.
  • Traditional models struggle with imbalanced HF data and poor feature representation.
  • Accurate prediction aids in timely interventions and improved patient management.

Purpose of the Study:

  • To propose a novel, fast, and accurate deep learning framework for HF mortality prediction.
  • To address the challenges of data imbalance and feature representation in HF datasets.
  • To enhance the clinical utility of predictive models for heart failure.

Main Methods:

  • A feature rearrangement-based deep learning system was developed.
  • A novel 'Feature rearrangement based convolutional layer' was introduced.
  • The framework incorporates techniques to handle data imbalance, such as Focal loss.

Main Results:

  • The proposed framework achieved superior performance in HF mortality prediction compared to existing methods.
  • Highest average accuracy and area under the curve were observed for in-hospital, 30-day, and 1-year mortality.
  • The study identified top 12 essential clinical features for HF prediction.

Conclusions:

  • The developed deep learning method accurately predicts HF mortality across different timeframes.
  • Feature rearrangement and Focal loss significantly improved prediction accuracy, especially in imbalanced datasets.
  • The framework offers a robust pipeline for modeling electronic health records (EHRs) and managing imbalanced medical data.